Medicare Enrolled
Dr. Stephen Finn, MD
Gastroenterology · Rome, GA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Finn from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Finn?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Finn
Dr. Stephen Finn is a gastroenterology specialist in Rome, GA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Finn performed 1,889 Medicare services across 1,716 unique beneficiaries.
Between the years covered by Open Payments, Dr. Finn received a total of $2,911 from 29 pharmaceutical and/or device companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gastroenterology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Finn is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 8% volume in GA
$2,911 industry payments
Medicare Practice Summary
Medicare Utilization ↗1,889
Medicare services
Top 8% in GA for gastroenterology
1,716
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~99 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
210 | $8 | $15 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
201 | $80 | $157 |
| Colon polyp removal with endoscopic snare This procedure removes polyps or growths from the large bowel using a flexible tube with a camera and a wire loop tool. The snare is used to cut off the growths during the examination. |
191 | $202 | $1,350 |
| Upper endoscopy (EGD) A diagnostic exam of the esophagus, stomach, and upper small bowel using a flexible endoscope. |
157 | $77 | $734 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
147 | $7 | $40 |
| Colonoscopy for colorectal cancer screening, high risk A colonoscopy performed to screen for colorectal cancer in individuals identified as being at high risk for the disease. |
126 | $174 | $943 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
110 | $95 | $211 |
| Dilation of esophagus | 80 | $35 | $310 |
| Upper GI endoscopy with biopsy A procedure to collect tissue samples from the esophagus, stomach, or upper small intestine using a flexible tube with a camera. The samples are examined to check for abnormalities. |
78 | $86 | $827 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
75 | $10 | $60 |
| Colonoscopy A diagnostic exam of the large bowel using a flexible endoscope to visualize the interior of the colon. |
65 | $126 | $1,086 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
55 | $65 | $109 |
| Limited abdominal ultrasound A focused ultrasound examination of the abdomen to evaluate specific organs or areas. This procedure uses sound waves to create images of internal structures. |
49 | $36 | $183 |
| Colonoscopy for colorectal cancer screening A colonoscopy performed to screen for colorectal cancer in individuals who are not at high risk for the disease. |
49 | $175 | $975 |
| Colonoscopy with biopsy A procedure to collect tissue samples from the large intestine using a flexible tube with a camera. The samples are examined to check for abnormalities or disease. |
43 | $91 | $1,130 |
| Liver function blood test panel | 36 | $8 | $50 |
| Prothrombin time test (blood clotting) A laboratory test that measures how long it takes for blood to clot. This procedure evaluates the body's coagulation process. |
34 | $4 | $30 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
31 | $13 | $85 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
30 | $60 | $113 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
30 | $85 | $167 |
| Blood creatinine level test A blood test that measures the amount of creatinine, a waste product from muscle wear and tear, to help assess kidney function. |
24 | $5 | $30 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
16 | $134 | $299 |
| Iron level test | 14 | $6 | $30 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
14 | $8 | $45 |
| Balloon dilation of esophagus, stomach, or upper small bowel, less than 3.0 cm A procedure using a flexible endoscope to widen a narrowed section of the esophagus, stomach, or upper small bowel with a balloon that is less than 3.0 cm in length. |
12 | $104 | $520 |
| Injection beneath large bowel lining via endoscope A flexible endoscope is used to inject medication or fluid beneath the lining of the large intestine. |
12 | $12 | $925 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$2,911
Total received (2018-2024)
Avg $416/year across 7 years
Bottom 44% in GA for gastroenterology
29
Companies
206
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,846 (97.8%)
Other
Charitable contributions, space rental, and other categories
$49 (1.7%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$16 (0.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$302
2023
$292
2022
$327
2021
$226
2020
$275
2019
$770
2018
$719
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$77
ABBVIE INC.
$50
Takeda Pharmaceuticals U.S.A., Inc.
$49
Janssen Biotech, Inc.
$22
Olympus America Inc.
$20
Phathom Pharmaceuticals, Inc.
$18
Intercept Pharmaceuticals, Inc.
$18
Boston Scientific Corporation
$17
INTUITIVE SURGICAL, INC.
$16
IRONWOOD PHARMACEUTICALS, INC
$16
Top 3 companies account for 58.3% of 2024 payments
All-time payments by company (2018-2024) ›
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$907
AbbVie, Inc.
$419
Takeda Pharmaceuticals U.S.A., Inc.
$254
Allergan Inc.
$181
ABBVIE INC.
$147
Boston Scientific Corporation
$144
Janssen Biotech, Inc.
$125
UCB, Inc.
$90
Intercept Pharmaceuticals, Inc.
$65
BOSTON SCIENTIFIC CORPORATION
$63
Daiichi Sankyo Inc.
$59
AbbVie Inc.
$58
FUJIFILM Healthcare Americas Corporation
$49
Shire North American Group Inc
$39
Merck Sharp & Dohme Corporation
$38
Synergy Pharmaceuticals Inc
$38
INTERCEPT PHARMACEUTICALS, INC.
$36
Otsuka America Pharmaceutical, Inc.
$20
Olympus America Inc.
$20
Celgene Corporation
$20
GENZYME CORPORATION
$18
Phathom Pharmaceuticals, Inc.
$18
Allergan, Inc.
$17
INTUITIVE SURGICAL, INC.
$16
IRONWOOD PHARMACEUTICALS, INC
$16
PFIZER INC.
$16
QOL Medical, LLC
$14
Braintree Laboratories, Inc.
$13
Dova Pharmaceuticals
$11
Top 3 companies account for 54.3% of all-time payments
Associated products mentioned in payments ›
APRISO · Amitiza · BREATHTEK · CREON · Cimzia · Creon · DIFICID · DUPIXENT · Da Vinci Surgical System · Doptelet · ENTYVIO · EVIS EXERA III COLONOVIDEOSCOPE · EXALT · Entyvio · FUJIFILM · GATTEX · GENERAL HEMOSTASIS · GENERAL POLYPECTOMY · GENERAL - ENDOCHOICE · General - GI Dilatation · General - Polypectomy · HUMIRA · Humira · INJECTAFER · LINZESS · Linzess · OCALIVA · QULIPTA · RENFLEXIS · RESOLUTION CLIP · RINVOQ · Resolution 360 Clip · STELARA · SUPREP · Sucraid · TRULANCE · Trulance · VIBERZI · VOQUEZNA · XELJANZ · XIFAXAN · ZENPEP · ZEPOSIA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gastroenterologists within 10 mi
12
Per 100K population
12.1
County median income
$62,540
Nearest hospital
ADVENTHEALTH REDMOND
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Finn is a mixed practice specialist, with above-average Medicare volume (top 8% in GA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Finn experienced with blood draw (venipuncture)?
Based on Medicare claims data, Dr. Finn performed 210 blood draw (venipuncture) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Finn receive payments from pharmaceutical companies?
Yes. Dr. Finn received a total of $2,911 from 29 companies across 206 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Finn's costs compare to other gastroenterologists in Rome?
Dr. Finn's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Finn) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Gastroenterology
Common procedures, typical costs, and what industry payments mean in gastroenterology.
Same specialty & city
Gastroenterologists in Rome
Browse gastroenterologists in Rome ranked by procedure volume and transparency data.
Highest volume
Top Gastroenterologists in GA
Gastroenterologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gastroenterologists in GA
Which GA gastroenterologists receive the most from drug and device companies.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Takeda Pharmaceuticals U.S.A., Inc. Payments to Doctors
See all physicians who received payments from Takeda Pharmaceuticals U.S.A., Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology